![Robert Whelan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Whelan
Presidente presso
Whelan & Co. LLC
Profilo
Robert M. Whelan occupa la posizione di presidente di Aspen Technology, Inc. e presidente di Whelan & Co. LLC. È anche nel consiglio di amministrazione di iAnthus Capital Holdings, Inc. In precedenza ha occupato la posizione di amministratore delegato presso Valuation Perspectives, Inc., amministratore delegato e responsabile della finanza aziendale presso Hambrecht & Quist, Inc., presidente di Prudential Volpe Technology Group, direttore operativo di Volpe Brown Whelan & Co. LLC, MD-New York Regional & High Technology Groups presso Prudential Securities, membro del consiglio di amministrazione presso SVB Leerink LLC e direttore presso Growth Capital Partners LP. Si è laureato al Dartmouth College e ha conseguito un MBA alla Stanford Graduate School of Business.
Posizioni attive di Robert Whelan
| Società | Posizione | Inizio |
|---|---|---|
Whelan & Co. LLC | Presidente | 01/01/2001 |
Vilua, Inc.
 Vilua, Inc. Information Technology ServicesTechnology Services Provides IT systems integration services | Direttore/Membro del Consiglio | 01/01/2021 |
Precedenti posizioni note di Robert Whelan
| Società | Posizione | Fine |
|---|---|---|
| ASPEN TECHNOLOGY, INC. | Presidente | 12/03/2025 |
| ASPEN TECHNOLOGY | Presidente | 02/08/2021 |
| IANTHUS CAPITAL HOLDINGS, INC. | Direttore/Membro del Consiglio | 18/01/2022 |
| ANNOVIS BIO, INC. | Direttore/Membro del Consiglio | 14/03/2021 |
| ARIAD PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/09/2014 |
Formazione di Robert Whelan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
AspenTech Corp.
 AspenTech Corp. Packaged SoftwareTechnology Services Operates as an asset management software company | Technology Services |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Growth Capital Partners LP
 Growth Capital Partners LP Investment ManagersFinance Growth Capital Partners LP (GCP) assists middle-market companies with private placements of equity or equity-related capital to fund internal growth and strategic acquisitions. All of the firm's activities are involved in the private equity marketplace. GCP does not divert resources to other activities such as sales and/or trading. The Southwest Mezzanine Fund I LP makes opportunistic investments in companies located in the Southwestern US. The firm invests across a variety of industries but does not invest in start-ups, turnarounds, real estate or oil & gas. Historically, GCP has invested in the energy, manufacturing, distribution, business services/staffing, consumer/retail, technology/software and healthcare. The Fund seeks to invest in companies with annual revenues of at least $15 million and a cash flow margin of at least 10%. GCP seeks to identify companies: (1) with experienced management teams (2) with proven stable cash flows (3) that operate in established industries (4) that possess a growing market share and (5) are unleveraged or low leveraged. Investments range from $2 million to $8 million and are structured as subordinated debt with a 3 to 5-year term, with current interest payable and equity participation for GCP. Coupon rates are 12% to 14%. GCP requires board observation rights. There are no penalties for prepayment and ownership ratchets are offered as incentives for early principal repayment. The Fund's capital is typically used for expansion capital, acquisition financing and recapitalizations. | Finance |
Annovis Bio, Inc.
 Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Prudential Volpe Technology Group
 Prudential Volpe Technology Group Investment Banks/BrokersFinance Provides brokerage services | Finance |
Volpe Brown Whelan & Co. LLC
 Volpe Brown Whelan & Co. LLC Investment Banks/BrokersFinance Investment firm | Finance |
Valuation Perspectives, Inc. | |
Whelan & Co. LLC | |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hambrecht & Quist, Inc.
 Hambrecht & Quist, Inc. Investment Banks/BrokersFinance Provides underwriting and investment services | Finance |
iAnthus Capital Holdings, Inc.
 iAnthus Capital Holdings, Inc. Agricultural Commodities/MillingProcess Industries Engages in cultivation, processing and dispensing of cannabis and cannabidiol products | Process Industries |
Vilua, Inc.
Vilua, Inc. Information Technology ServicesTechnology Services Provides IT systems integration services | Technology Services |
Aspen Technology, Inc.
 Aspen Technology, Inc. Packaged SoftwareTechnology Services Develops software for asset performance, monitoring management and optimization solutions | Technology Services |
